96 related articles for article (PubMed ID: 10497853)
1. Coexistence of multiple myeloma and chronic myelogenous leukemia.
Tanaka M; Tanaka K; Oizumi K
Int J Hematol; 1999 Aug; 70(2):132-3. PubMed ID: 10497853
[No Abstract] [Full Text] [Related]
2. Simultaneous occurrence of multiple myeloma and chronic myeloid leukemia.
Alvarez-Larrán A; Rozman M; Cervantes F
Haematologica; 2001 Aug; 86(8):894. PubMed ID: 11524262
[No Abstract] [Full Text] [Related]
3. Multiple myeloma developing after imatinib mesylate therapy for chronic myeloid leukemia.
Galanopoulos A; Papadhimitriou SI; Kritikou-Griva E; Georgiakaki M; Anagnostopoulos NI
Ann Hematol; 2009 Mar; 88(3):281-2. PubMed ID: 18726593
[No Abstract] [Full Text] [Related]
4. Development of multiple myeloma in a patient with chronic myeloid leukemia after treatment with imatinib mesylate.
Garipidou V; Vakalopoulou S; Tziomalos K
Oncologist; 2005; 10(6):457-8. PubMed ID: 15967839
[No Abstract] [Full Text] [Related]
5. "True" histiocytic lymphoma of the stomach associated with colonic cancer and complicated by chronic myeloid leukemia.
Melato M; Laurino L; Pozzato G
Haematologica; 1989; 74(5):521-2. PubMed ID: 2511125
[No Abstract] [Full Text] [Related]
6. Occurrence of multiple myeloma in both donor and recipient after bone marrow transplantation.
Kumar A; Styler MJ; Topolsky DL; Crilley PA; Przybysz TM; Gladstone DE
Am J Hematol; 2002 Nov; 71(3):227-8. PubMed ID: 12410583
[TBL] [Abstract][Full Text] [Related]
7. Leukemias and plasma cell myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1999; 18():268-92. PubMed ID: 10800488
[No Abstract] [Full Text] [Related]
8. [Multiple neoplasms: presentation of a new case].
Martín E; Castellsague J; Ordi J; López R; Saigi E; Mercade V
Rev Clin Esp; 1989; 185(3):168-9. PubMed ID: 2623232
[No Abstract] [Full Text] [Related]
9. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
[TBL] [Abstract][Full Text] [Related]
10. Multiple haematological malignancies in a patient with rheumatoid arthritis without exposure to disease modifying therapy.
Piper H; Mulherin D; Hardwick N
Ann Rheum Dis; 2006 Feb; 65(2):268-9. PubMed ID: 16410533
[No Abstract] [Full Text] [Related]
11. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
[TBL] [Abstract][Full Text] [Related]
12. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea.
Moon HW; Kim TY; Oh BR; Min HC; Cho HI; Bang SM; Lee JH; Yoon SS; Lee DS
Leuk Res; 2007 Sep; 31(9):1213-7. PubMed ID: 17156840
[TBL] [Abstract][Full Text] [Related]
13. [Diversity of BCR and ABL gene breakpoints in chronic myelogenous leukemia].
Sugimoto T
Rinsho Ketsueki; 2003 Feb; 44(2):61-4. PubMed ID: 12692976
[No Abstract] [Full Text] [Related]
14. Synchronous occurrence of Philadelphia chromosome-positive chronic myelogenous leukemia and breast cancer.
Tillawi IS
Saudi Med J; 2007 Feb; 28(2):291-4. PubMed ID: 17268717
[No Abstract] [Full Text] [Related]
15. Is there an entity of chemically induced BCR-ABL-positive chronic myelogenous leukemia?
Lichtman MA
Oncologist; 2008 Jun; 13(6):645-54. PubMed ID: 18586919
[TBL] [Abstract][Full Text] [Related]
16. Different immune reconstitution in multiple myeloma, chronic myeloid leukemia and acute myeloid leukemia patients after allogeneic transplantation of peripheral blood stem cells.
Rondelli D; Re F; Bandini G; Raspadori D; Arpinati M; Senese B; Stanzani M; Bonifazi F; Falcioni S; Chirumbolo G; Tura S
Bone Marrow Transplant; 2000 Dec; 26(12):1325-31. PubMed ID: 11223973
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Onida F; Ball G; Kantarjian HM; Smith TL; Glassman A; Albitar M; Scappini B; Rios MB; Keating MJ; Beran M
Cancer; 2002 Oct; 95(8):1673-84. PubMed ID: 12365015
[TBL] [Abstract][Full Text] [Related]
18. Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases.
Vefring HK; Gruber FX; Wee L; Hovland R; Hjorth-Hansen H; Gedde Dahl T; Meyer P
Acta Haematol; 2009; 122(1):11-6. PubMed ID: 19641300
[TBL] [Abstract][Full Text] [Related]
19. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
[TBL] [Abstract][Full Text] [Related]
20. Early prediction of molecular remission by monitoring BCR-ABL transcript levels in patients achieving a complete cytogenetic response after imatinib therapy for posttransplantation chronic myelogenous leukemia relapse.
Kim YJ; Kim DW; Lee S; Min CK; Goh HG; Kim SH; Lee JY; Kim YL; Kim HJ; Kim HJ; Lee JW; Kim TG; Min WS; Kim CC
Biol Blood Marrow Transplant; 2004 Oct; 10(10):718-25. PubMed ID: 15389438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
